Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI

Name: Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
License: Public Domain

Craig L Slingluff, Jr

ClinicalTrials.gov · Datasets · License: Public Domain

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 454040
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.